StemCell Institute (TSE:7096) EPS (Diluted) : 円30.35 (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is StemCell Institute EPS (Diluted)?

StemCell Institute's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was 円0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was 円30.35.

StemCell Institute's EPS (Basic) for the three months ended in Sep. 2024 was 円0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was 円30.35.

StemCell Institute's EPS without NRI for the three months ended in Sep. 2024 was 円0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was 円28.80.

During the past 12 months, StemCell Institute's average EPS without NRIGrowth Rate was 5.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 64.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, StemCell Institute's highest 3-Year average EPS without NRI Growth Rate was 64.30% per year. The lowest was -8.40% per year. And the median was -1.80% per year.

StemCell Institute EPS (Diluted) Historical Data

The historical data trend for StemCell Institute's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemCell Institute EPS (Diluted) Chart

StemCell Institute Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EPS (Diluted)

Get a 7-Day Free Trial

27.08

6.41

13.20

19.33

30.35

StemCell Institute Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
EPS (Diluted)	Get a 7-Day Free Trial														7.39	8.20	9.29	5.47	-

Competitive Comparison of StemCell Institute's EPS (Diluted)

For the Biotechnology subindustry, StemCell Institute's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StemCell Institute's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemCell Institute's PE Ratio distribution charts can be found below:

* The bar in red indicates where StemCell Institute's PE Ratio falls into.

StemCell Institute EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

StemCell Institute's Diluted EPS for the fiscal year that ended in Mar. 2024 is calculated as

Diluted EPS (A: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(310.981	-	0)	/	10.247
	=	30.35

StemCell Institute's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(0	-	0)	/	10.247
	=	0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円30.35

StemCell Institute (TSE:7096) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

StemCell Institute EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of StemCell Institute's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

StemCell Institute Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemCell Institute (TSE:7096) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shimbashi, Minato-ku, Tamuracho Building, Matsuoka, Tokyo, JPN, 105-0004

Website

https://www.stemcell.co.jp

StemCell Institute is engaged in Cell bank business that separates and stores cord blood for regenerative medicine. Cord blood is the baby's blood contained in the umbilical cord and placenta that connects mother and baby. In its umbilical cord blood storage business, upon receiving notification from customers who have contracted, umbilical cord blood collected at obstetric facilities throughout Japan is collected, transported to the company's own cell processing center within 48 hours, and it provides a service to store cells at ultra-low temperature after separating cells from blood.

StemCell Institute Headlines

No Headlines